United States Biotechnology & Medical Research

Crinetics Pharmaceuticals Inc (CRNX)

Track

Track

Crinetics Pharmaceuticals experienced significant insider selling activity over the past ninety days, totaling over 2.1 million dollars. Key executives and directors, including Jeff Knight and Rogerio Vivaldi Coelho, executed multiple planned divestments. These transactions occurred amidst a period of strong stock performance, following a positive earnings report that exceeded analyst expectations by 7.3 percent.
Ticker: CRNX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Crinetics Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.4
Vivaldi Coelho Rogerio Non-Executive Director
Transaction date
Planned sale
Price
125.58
Quantity 27,756 +18.1%
Value US$2,433,597
2.5
JEFF KNIGHT Officer Officer
Transaction date
Proposed sale
Price
312.11
Quantity 80,101
Value US$2,659,596
1.4
ROGERIO VIVALDI COELHO Director Non-Executive Director
Transaction date
Proposed sale
Price
492.87
Quantity 41,075
Value US$3,050,300
3.4
Okey Stephanie Non-Executive Director
Transaction date
Planned sale
Price
36.22
Quantity 608 -8.7%
Value US$22,022
3.4
Okey Stephanie Non-Executive Director
Transaction date
Planned sale
Price
35.62
Quantity 6,292 -47.3%
Value US$224,121
3.4
STEPHANIE OKEY Director Non-Executive Director
Transaction date
Proposed sale
Price
35.00
Quantity 6,900
Value US$241,500
2.5
JEFF KNIGHT Officer Officer
Transaction date
Proposed sale
Price
39.02
Quantity 9,485
Value US$370,105
2.5
JEFF KNIGHT Officer Officer
Transaction date
Proposed sale
Price
38.66
Quantity 20,900
Value US$807,994
2.5
JEFF KNIGHT Officer Officer
Transaction date
Proposed sale
Price
39.44
Quantity 4,434
Value US$174,877
2.5
Knight Jeff E. Chief Dev. & Operating Officer Officer
Transaction date
Planned sale
Price
40.10
Quantity 85,163 -44.7%
Value US$3,415,036
2.5
JEFF KNIGHT Officer Officer
Transaction date
Proposed sale
Price
38.41
Quantity 85,163
Value US$3,271,111
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
37.89
Quantity 24,756
Value US$938,005
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
37.77
Quantity 8,785 -2.1%
Value US$331,809
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
37.11
Quantity 13,196 -3.1%
Value US$489,704
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
37.77
Quantity 4,241 -3.0%
Value US$160,183
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
37.11
Quantity 6,371 -4.3%
Value US$236,428
Stephen Betz Officer Officer
Transaction date
Proposed sale
Price
37.49
Quantity 26,525
Value US$994,422
2.5
Jeff Knight Officer Officer
Transaction date
Proposed sale
Price
37.49
Quantity 25,113
Value US$941,486
2.3
Richard Scott Struthers Director; Officer Executive Director
Transaction date
Proposed sale
Price
37.49
Quantity 45,013
Value US$1,687,537
1.4
Vivaldi Coelho Rogerio Non-Executive Director
Transaction date
Planned sale
Price
36.77
Quantity 523 -3.1%
Value US$19,231
1.4
Vivaldi Coelho Rogerio Non-Executive Director
Transaction date
Planned sale
Price
36.08
Quantity 4,477 -21.0%
Value US$161,530
1.4
ROGERIO VIVALDI COELHO Director Non-Executive Director
Transaction date
Proposed sale
Price
36.98
Quantity 5,000
Value US$184,900
3.8
Schilke Tobin Chief Financial Officer Officer
Transaction date
Planned sale
Price
39.67
Quantity 6,713 -7.9%
Value US$266,305
3.4
Okey Stephanie Non-Executive Director
Transaction date
Planned sale
Price
39.67
Quantity 3,000 -18.4%
Value US$119,010
3.4
STEPHANIE S OKEY Director Non-Executive Director
Transaction date
Proposed sale
Price
40.68
Quantity 3,000
Value US$122,040
3.8
Tobin Schilke Officer Officer
Transaction date
Proposed sale
Price
41.18
Quantity 6,800
Value US$280,000
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
49.94
Quantity 10,000
Value US$499,400
Kalofonos Isabel Chief Commercial Officer Officer
Transaction date
Planned sale
Price
55.00
Quantity 2,500 -75.0%
Value US$137,500
ISABEL KALOFONOS Officer Officer
Transaction date
Proposed sale
Price
46.73
Quantity 2,500
Value US$116,825
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
46.55
Quantity 5,000
Value US$232,750
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
45.02
Quantity 5,000 -7.0%
Value US$225,100
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
45.56
Quantity 5,000
Value US$227,800
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
43.27
Quantity 100 -0.2%
Value US$4,327
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
42.65
Quantity 4,900 -6.9%
Value US$208,985
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
43.50
Quantity 5,000
Value US$217,500
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
41.81
Quantity 5,000 -7.0%
Value US$209,050
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
41.65
Quantity 5,000
Value US$208,250
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
45.00
Quantity 4,000 -3.6%
Value US$180,000
3.8
Fust Matthew K Non-Executive Director
Transaction date
Planned sale
Price
44.75
Quantity 16,000 -41.2%
Value US$716,000
2.3
Struthers Richard Scott Officer; Director Executive Director
Transaction date
Proposed sale
Price
45.00
Quantity 4,000
Value US$180,000
3.8
MATTHEW K FUST Director Non-Executive Director
Transaction date
Proposed sale
Price
35.89
Quantity 16,000
Value US$574,240
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
32.10
Quantity 5,000 -4.9%
Value US$160,500
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
30.99
Quantity 5,000
Value US$154,950
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
30.43
Quantity 30,000 -31.2%
Value US$912,900
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
29.40
Quantity 30,000
Value US$882,000
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
29.18
Quantity 6,492 -8.9%
Value US$189,437
1.9
DANA PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
29.43
Quantity 6,492
Value US$191,060
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
32.23
Quantity 97,483 -49.4%
Value US$3,141,877
STEPHEN BETZ Officer Officer
Transaction date
Proposed sale
Price
32.33
Quantity 97,483
Value US$3,151,625
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
34.83
Quantity 291 -0.3%
Value US$10,136
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
34.17
Quantity 5,479 -4.8%
Value US$187,217
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
34.83
Quantity 875 -0.3%
Value US$30,476
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
34.17
Quantity 16,463 -4.8%
Value US$562,541
2.5
Knight Jeff E. Chief Operating Officer Officer
Transaction date
Planned sale
Price
34.83
Quantity 361 -0.4%
Value US$12,574
2.5
Knight Jeff E. Chief Operating Officer Officer
Transaction date
Planned sale
Price
34.17
Quantity 6,801 -7.2%
Value US$232,390
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
34.83
Quantity 127 -0.2%
Value US$4,423
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
34.17
Quantity 2,388 -3.2%
Value US$81,598
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
39.07
Quantity 5,000 -13.6%
Value US$195,350
1.9
DANA J PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
39.07
Quantity 5,000
Value US$195,372
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
52.09
Quantity 15,000 -33.9%
Value US$781,350
1.9
DANA J PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
52.09
Quantity 15,000
Value US$781,323
2.3
Struthers Richard Scott President & CEO Executive Director
Transaction date
Planned sale
Price
57.57
Quantity 10,000 -9.1%
Value US$575,700
2.3
Struthers Richard Scott Officer Officer
Transaction date
Proposed sale
Price
57.27
Quantity 10,000
Value US$572,700
2.5
Knight Jeff E. Chief Operating Officer Officer
Transaction date
Planned sale
Price
56.52
Quantity 501 -1.0%
Value US$28,317
1.9
Pizzuti Dana Chief Med and Dev Officer Officer
Transaction date
Planned sale
Price
54.63
Quantity 14,375 -33.5%
Value US$785,306
1.9
DANA J PIZZUTI Officer Officer
Transaction date
Proposed sale
Price
54.63
Quantity 14,375
Value US$785,322
1.5
Wilson Marc CFO Officer
Transaction date
Planned sale
Price
51.11
Quantity 25,000 -18.4%
Value US$1,277,750
1.5
MARC WILSON Officer Officer
Transaction date
Proposed sale
Price
51.11
Quantity 25,000
Value US$1,277,625
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
51.50
Quantity 1,035 -1.5%
Value US$53,302
Betz Stephen F. Officer; Co-Founder Officer
Transaction date
Proposed sale
Price
51.50
Quantity 1,035
Value US$53,301
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
53.19
Quantity 3,000 -4.1%
Value US$159,570
Betz Stephen F. Officer; Co-Founder Officer
Transaction date
Proposed sale
Price
53.19
Quantity 3,000
Value US$159,570
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
47.68
Quantity 3,000 -4.0%
Value US$143,040
Betz Stephen F. Officer; Co-Founder Officer
Transaction date
Proposed sale
Price
47.68
Quantity 3,000
Value US$143,050
Betz Stephen F. Chief Scientific Officer Officer
Transaction date
Planned sale
Price
53.43
Quantity 3,000 -3.8%
Value US$160,290
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-02 PlS Planned sale
1.4
Vivaldi Coelho Rogerio
Non-Executive Director
27,756 +18.1%
125.58
US$2,433,597 		27,756 +18.1% 125.58 US$2,433,597
2026-07-02 2026-07-02 PrS Proposed sale
2.5
JEFF KNIGHT

Officer

Officer
80,101
312.11
US$2,659,596 		80,101 312.11 US$2,659,596
2026-07-02 2026-07-02 PrS Proposed sale
1.4
ROGERIO VIVALDI COELHO

Director

Non-Executive Director
41,075
492.87
US$3,050,300 		41,075 492.87 US$3,050,300
2026-06-18 2026-06-17 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
608 -8.7%
36.22
US$22,022 		608 -8.7% 36.22 US$22,022
2026-06-18 2026-06-17 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
6,292 -47.3%
35.62
US$224,121 		6,292 -47.3% 35.62 US$224,121
2026-06-17 2026-06-17 PrS Proposed sale
3.4
STEPHANIE OKEY

Director

Non-Executive Director
6,900
35.00
US$241,500 		6,900 35.00 US$241,500
2026-05-04 2026-05-04 PrS Proposed sale
2.5
JEFF KNIGHT

Officer

Officer
9,485
39.02
US$370,105 		9,485 39.02 US$370,105
2026-04-14 2026-04-14 PrS Proposed sale
2.5
JEFF KNIGHT

Officer

Officer
20,900
38.66
US$807,994 		20,900 38.66 US$807,994
2026-04-13 2026-04-13 PrS Proposed sale
2.5
JEFF KNIGHT

Officer

Officer
4,434
39.44
US$174,877 		4,434 39.44 US$174,877
2026-04-10 2026-04-08 PlS Planned sale
2.5
Knight Jeff E.

Chief Dev. & Operating Officer

Officer
85,163 -44.7%
40.10
US$3,415,036 		85,163 -44.7% 40.10 US$3,415,036
2026-04-08 2026-04-08 PrS Proposed sale
2.5
JEFF KNIGHT

Officer

Officer
85,163
38.41
US$3,271,111 		85,163 38.41 US$3,271,111
2026-03-18 2026-03-18 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
24,756
37.89
US$938,005 		24,756 37.89 US$938,005
2026-03-18 2026-03-16 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
8,785 -2.1%
37.77
US$331,809 		8,785 -2.1% 37.77 US$331,809
2026-03-18 2026-03-16 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
13,196 -3.1%
37.11
US$489,704 		13,196 -3.1% 37.11 US$489,704
2026-03-18 2026-03-16 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
4,241 -3.0%
37.77
US$160,183 		4,241 -3.0% 37.77 US$160,183
2026-03-18 2026-03-16 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
6,371 -4.3%
37.11
US$236,428 		6,371 -4.3% 37.11 US$236,428
2026-03-16 2026-03-16 PrS Proposed sale
Stephen Betz

Officer

Officer
26,525
37.49
US$994,422 		26,525 37.49 US$994,422
2026-03-16 2026-03-16 PrS Proposed sale
2.5
Jeff Knight

Officer

Officer
25,113
37.49
US$941,486 		25,113 37.49 US$941,486
2026-03-16 2026-03-16 PrS Proposed sale
2.3
Richard Scott Struthers

Director; Officer

Executive Director
45,013
37.49
US$1,687,537 		45,013 37.49 US$1,687,537
2026-03-13 2026-03-12 PlS Planned sale
1.4
Vivaldi Coelho Rogerio
Non-Executive Director
523 -3.1%
36.77
US$19,231 		523 -3.1% 36.77 US$19,231
2026-03-13 2026-03-12 PlS Planned sale
1.4
Vivaldi Coelho Rogerio
Non-Executive Director
4,477 -21.0%
36.08
US$161,530 		4,477 -21.0% 36.08 US$161,530
2026-03-12 2026-03-12 PrS Proposed sale
1.4
ROGERIO VIVALDI COELHO

Director

Non-Executive Director
5,000
36.98
US$184,900 		5,000 36.98 US$184,900
2026-03-04 2026-03-03 PlS Planned sale
3.8
Schilke Tobin

Chief Financial Officer

Officer
6,713 -7.9%
39.67
US$266,305 		6,713 -7.9% 39.67 US$266,305
2026-03-04 2026-03-03 PlS Planned sale
3.4
Okey Stephanie
Non-Executive Director
3,000 -18.4%
39.67
US$119,010 		3,000 -18.4% 39.67 US$119,010
2026-03-03 2026-03-03 PrS Proposed sale
3.4
STEPHANIE S OKEY

Director

Non-Executive Director
3,000
40.68
US$122,040 		3,000 40.68 US$122,040
2026-03-02 2026-03-02 PrS Proposed sale
3.8
Tobin Schilke

Officer

Officer
6,800
41.18
US$280,000 		6,800 41.18 US$280,000
2026-02-02 2026-02-02 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
10,000
49.94
US$499,400 		10,000 49.94 US$499,400
2026-01-07 2026-01-05 PlS Planned sale
Kalofonos Isabel

Chief Commercial Officer

Officer
2,500 -75.0%
55.00
US$137,500 		2,500 -75.0% 55.00 US$137,500
2026-01-05 2026-01-05 PrS Proposed sale
ISABEL KALOFONOS

Officer

Officer
2,500
46.73
US$116,825 		2,500 46.73 US$116,825
2026-01-02 2026-01-02 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
5,000
46.55
US$232,750 		5,000 46.55 US$232,750
2025-12-03 2025-12-01 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
5,000 -7.0%
45.02
US$225,100 		5,000 -7.0% 45.02 US$225,100
2025-12-01 2025-12-01 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
5,000
45.56
US$227,800 		5,000 45.56 US$227,800
2025-11-05 2025-11-03 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
100 -0.2%
43.27
US$4,327 		100 -0.2% 43.27 US$4,327
2025-11-05 2025-11-03 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
4,900 -6.9%
42.65
US$208,985 		4,900 -6.9% 42.65 US$208,985
2025-11-03 2025-11-03 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
5,000
43.50
US$217,500 		5,000 43.50 US$217,500
2025-10-03 2025-10-01 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
5,000 -7.0%
41.81
US$209,050 		5,000 -7.0% 41.81 US$209,050
2025-10-01 2025-10-01 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
5,000
41.65
US$208,250 		5,000 41.65 US$208,250
2025-09-30 2025-09-26 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
4,000 -3.6%
45.00
US$180,000 		4,000 -3.6% 45.00 US$180,000
2025-09-30 2025-09-26 PlS Planned sale
3.8
Fust Matthew K
Non-Executive Director
16,000 -41.2%
44.75
US$716,000 		16,000 -41.2% 44.75 US$716,000
2025-09-26 2025-09-26 PrS Proposed sale
2.3
Struthers Richard Scott

Officer; Director

Executive Director
4,000
45.00
US$180,000 		4,000 45.00 US$180,000
2025-09-26 2025-09-26 PrS Proposed sale
3.8
MATTHEW K FUST

Director

Non-Executive Director
16,000
35.89
US$574,240 		16,000 35.89 US$574,240
2025-09-04 2025-09-02 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
5,000 -4.9%
32.10
US$160,500 		5,000 -4.9% 32.10 US$160,500
2025-09-02 2025-09-02 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
5,000
30.99
US$154,950 		5,000 30.99 US$154,950
2025-08-26 2025-08-22 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
30,000 -31.2%
30.43
US$912,900 		30,000 -31.2% 30.43 US$912,900
2025-08-22 2025-08-22 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
30,000
29.40
US$882,000 		30,000 29.40 US$882,000
2025-08-21 2025-08-20 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
6,492 -8.9%
29.18
US$189,437 		6,492 -8.9% 29.18 US$189,437
2025-08-20 2025-08-20 PrS Proposed sale
1.9
DANA PIZZUTI

Officer

Officer
6,492
29.43
US$191,060 		6,492 29.43 US$191,060
2025-06-16 2025-06-12 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
97,483 -49.4%
32.23
US$3,141,877 		97,483 -49.4% 32.23 US$3,141,877
2025-06-12 2025-06-12 PrS Proposed sale
STEPHEN BETZ

Officer

Officer
97,483
32.33
US$3,151,625 		97,483 32.33 US$3,151,625
2025-03-21 2025-03-19 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
291 -0.3%
34.83
US$10,136 		291 -0.3% 34.83 US$10,136
2025-03-21 2025-03-19 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
5,479 -4.8%
34.17
US$187,217 		5,479 -4.8% 34.17 US$187,217
2025-03-21 2025-03-19 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
875 -0.3%
34.83
US$30,476 		875 -0.3% 34.83 US$30,476
2025-03-21 2025-03-19 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
16,463 -4.8%
34.17
US$562,541 		16,463 -4.8% 34.17 US$562,541
2025-03-21 2025-03-19 PlS Planned sale
2.5
Knight Jeff E.

Chief Operating Officer

Officer
361 -0.4%
34.83
US$12,574 		361 -0.4% 34.83 US$12,574
2025-03-21 2025-03-19 PlS Planned sale
2.5
Knight Jeff E.

Chief Operating Officer

Officer
6,801 -7.2%
34.17
US$232,390 		6,801 -7.2% 34.17 US$232,390
2025-03-21 2025-03-19 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
127 -0.2%
34.83
US$4,423 		127 -0.2% 34.83 US$4,423
2025-03-21 2025-03-19 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
2,388 -3.2%
34.17
US$81,598 		2,388 -3.2% 34.17 US$81,598
2025-02-05 2025-02-03 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
5,000 -13.6%
39.07
US$195,350 		5,000 -13.6% 39.07 US$195,350
2025-02-03 2025-02-03 PrS Proposed sale
1.9
DANA J PIZZUTI

Officer

Officer
5,000
39.07
US$195,372 		5,000 39.07 US$195,372
2025-01-07 2025-01-03 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
15,000 -33.9%
52.09
US$781,350 		15,000 -33.9% 52.09 US$781,350
2025-01-03 2025-01-03 PrS Proposed sale
1.9
DANA J PIZZUTI

Officer

Officer
15,000
52.09
US$781,323 		15,000 52.09 US$781,323
2024-12-04 2024-12-02 PlS Planned sale
2.3
Struthers Richard Scott

President & CEO

Executive Director
10,000 -9.1%
57.57
US$575,700 		10,000 -9.1% 57.57 US$575,700
2024-12-02 2024-12-02 PrS Proposed sale
2.3
Struthers Richard Scott

Officer

Officer
10,000
57.27
US$572,700 		10,000 57.27 US$572,700
2024-11-26 2024-11-22 PlS Planned sale
2.5
Knight Jeff E.

Chief Operating Officer

Officer
501 -1.0%
56.52
US$28,317 		501 -1.0% 56.52 US$28,317
2024-10-07 2024-10-03 PlS Planned sale
1.9
Pizzuti Dana

Chief Med and Dev Officer

Officer
14,375 -33.5%
54.63
US$785,306 		14,375 -33.5% 54.63 US$785,306
2024-10-03 2024-10-03 PrS Proposed sale
1.9
DANA J PIZZUTI

Officer

Officer
14,375
54.63
US$785,322 		14,375 54.63 US$785,322
2024-09-30 2024-09-26 PlS Planned sale
1.5
Wilson Marc

CFO

Officer
25,000 -18.4%
51.11
US$1,277,750 		25,000 -18.4% 51.11 US$1,277,750
2024-09-26 2024-09-26 PrS Proposed sale
1.5
MARC WILSON

Officer

Officer
25,000
51.11
US$1,277,625 		25,000 51.11 US$1,277,625
2024-09-12 2024-09-10 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
1,035 -1.5%
51.50
US$53,302 		1,035 -1.5% 51.50 US$53,302
2024-09-10 2024-09-10 PrS Proposed sale
Betz Stephen F.

Officer; Co-Founder

Officer
1,035
51.50
US$53,301 		1,035 51.50 US$53,301
2024-08-28 2024-08-26 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
3,000 -4.1%
53.19
US$159,570 		3,000 -4.1% 53.19 US$159,570
2024-08-26 2024-08-26 PrS Proposed sale
Betz Stephen F.

Officer; Co-Founder

Officer
3,000
53.19
US$159,570 		3,000 53.19 US$159,570
2024-08-14 2024-08-12 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
3,000 -4.0%
47.68
US$143,040 		3,000 -4.0% 47.68 US$143,040
2024-08-12 2024-08-12 PrS Proposed sale
Betz Stephen F.

Officer; Co-Founder

Officer
3,000
47.68
US$143,050 		3,000 47.68 US$143,050
2024-07-26 2024-07-25 PlS Planned sale
Betz Stephen F.

Chief Scientific Officer

Officer
3,000 -3.8%
53.43
US$160,290 		3,000 -3.8% 53.43 US$160,290
Explore more

More insider trading research around Crinetics Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America